KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) EBT Margin (2016 - 2026)

Globus Medical filings provide 15 years of EBT Margin readings, the most recent being 20.48% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 1673.0% to 20.48% in Q4 2025 year-over-year; TTM through Dec 2025 was 20.59%, a 1580.0% increase, with the full-year FY2025 number at 20.59%, up 1580.0% from a year prior.
  • EBT Margin hit 20.48% in Q4 2025 for Globus Medical, up from 18.72% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 26.76% in Q2 2022 to a low of 1.42% in Q1 2024.
  • Median EBT Margin over the past 5 years was 19.99% (2025), compared with a mean of 16.42%.
  • The widest YoY moves for EBT Margin: up 3423bps in 2021, down -2914bps in 2021.
  • Globus Medical's EBT Margin stood at 9.7% in 2021, then surged by 149bps to 24.17% in 2022, then tumbled by -83bps to 4.05% in 2023, then decreased by -7bps to 3.75% in 2024, then soared by 446bps to 20.48% in 2025.
  • The last three reported values for EBT Margin were 20.48% (Q4 2025), 18.72% (Q3 2025), and 25.25% (Q2 2025) per Business Quant data.